3 / 12
Page 54
Volume 3
Journal of Nursing Research and Practice
Nursing and Heart 2019
April 22-23, 2019
Nursing Education and Evidence Based Practice Conference
Heart Conference
April 22-23, 2019 Dubai, UAE
World
4
th
International
&
Modern treatment methods of heart failure
UA Eyubova
and
MM Bakhshiyev
Azerbaijan Medical University, Azerbaijan
B
eing a very common condition among the whole population of the world, often leading a life-threatening illness and having high
risk and mortality rate, chronic heart failure is also a major public health problem for the world. According to data provided
in 2017, 26 million people worldwide suffer from heart failure. These reasons include especially malnutrition and obesity, diabetes
mellitus that is increasing every year, increase in smoking, hypertension, and an increase of alcohol consumption. Our goal is
to investigate what has been achieved in the treatment of chronic heart failure patients with a Left Ventricular Ejection Fraction
(LVEF) < 40% recent years. In recent years, it is revealed that brain natriuretic peptide has been crucial in the pathogenesis of heart
disease. The activity of natriuretic peptides, in particular B-type natriuretic peptide, causes a number of significant cardiac and renal
effects. Thus, B-type natriuretic peptide has a significant role in the diagnosis of heart failure and in the evaluation of its prognosis.
However, natriuretic peptides can not last long in the body and break down quickly. This process is mainly due to neprilysin and that
is why, neprilysin inhibition is needed in order to prevent the process. Due to this reason, we tried to investigate the results of the
complex medical treatment method performed with the combination of sacubitril / valsartan which is neprilysin inhibitor in chronic
heart failure patients. We also investigated the device treatment methods used in the treatment of these patients, particularly the
cardiac resynchronization therapy. Finally, we investigated the results of the complex medical treatment method performed with the
combination of sacubitril / valsartan in comparison with the results of the device treatment methods.
Biography
Ulviyya Eyubova is the member of Azerbaijan Society of Cardiology. She pursues her Ph.D. at Azerbaijan Medical University. She also works in Central Clinic
Hospital in Baku, Azerbaijan.
eyubovaulviyya@mail.ruUA Eyubova et al., J Nursing Research and Practice, Volume 3
DOI: 10.4172/2632-251X-C3-009